Madrigal Pharmaceuticals, Inc.
USD527.28
+14.63 (+2.85%)
CEO
William J. Sibold
IPO Date
2007-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$517.99
Prev. Close
$512.65
Day Low
$506.00
Day High
$531.04
52W Low
$284.02
52W High
$615.00
Market Cap
$12.16B
Volume
0.45M
| -14.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -92.2% | -58.3% | 0.29 | 5.38 | -11.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -149.6% | -81.5% | 0.25 | 3.12 | -16.8 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -123.3% | -88.5% | 0.00 | 3.54 | -5.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -84.3% | -70.5% | 0.00 | 6.13 | -8.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -20.2% | -19.0% | 0.00 | 17.52 | -16.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -6.9% | -6.8% | 0.00 | 57.46 | -50.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -17.1% | -16.2% | 0.00 | 19.10 | -36.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -72.5% | -64.0% | 0.00 | 8.58 | -2.9 |
| -55.8 |
| 30 Sept 2025 | Q3 | 93.7% | -39.8% | -18.2% | -8.4% | 0.55 | 3.44 | -22.6 |
| 30 Jun 2025 | Q2 | 95.7% | -19.9% | -6.1% | -4.2% | 0.18 | 5.11 | -39.7 |
| 31 Mar 2025 | Q1 | 96.7% | -53.4% | -10.3% | -7.3% | 0.17 | 5.91 | -25.0 |
| 31 Dec 2024 | Q4 | 96.7% | -57.5% | -7.9% | -5.7% | 0.16 | 6.10 | -28.5 |
| 30 Sept 2024 | Q3 | 96.5% | -172.0% | -13.8% | -10.0% | 0.15 | 5.98 | -10.8 |
| 30 Jun 2024 | Q2 | 95.7% | -1038.2% | -17.7% | -13.8% | 0.14 | 8.72 | -9.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -17.3% | -13.6% | 0.14 | 9.39 | -8.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -27.7% | -17.5% | 0.29 | 5.38 | -10.2 |